The quantum computing sector is known for violent swings, and IonQ’s recent price action has been no exception. After shedding roughly 11% over the past week on interest-rate jitters and fading AI enthusiasm, the stock bounced back with a 10.94% gain on Monday, closing at €54.88. The rebound reflects a mix of company-specific catalysts and renewed sector optimism, but the lingering macro overhang keeps the trajectory uncertain.
The centrepiece of IonQ’s strategic transformation is the planned $1.8 billion acquisition of SkyWater Technology, expected to close in the second or third quarter. The deal is designed to bring chip design, fabrication and packaging under one roof, reducing reliance on external suppliers and shortening development cycles. That vertical integration is especially critical for IonQ’s ambitious roadmap to build quantum processors with 200,000 qubits, with functional tests targeted for 2028. If the integration succeeds, IonQ would carve out a more industrial path than many of its research-focused peers.
Government demand is bolstering the narrative. IonQ secured a $39 million contract under the Space Development Agency’s HALO programme for tactical space communications and operational quantum-space systems. Such awards add revenue visibility and credibility. Government and education contracts now represent roughly 50% of IonQ’s total deal volume, and its remaining performance obligations hit a record $470 million in the first quarter. Notably, the US Department of Commerce recently signed letters of intent with nine quantum computing companies, unlocking $2 billion from the CHIPS and Science Act — but IonQ was not among the direct recipients. The sector tailwind is broad, not company-specific.
Financial results underscore the tension between rapid growth and deep losses. First-quarter revenue surged to $64.7 million, a 755% jump year-over-year, prompting management to lift its full-year guidance to $260–$270 million from a prior range of $225–$245 million. Organic growth is expected to exceed 100%. Yet the adjusted EBITDA loss for the quarter stood at $96.8 million, and the company projects a full-year shortfall of $310–$330 million. The cash position, however, remains robust at $3.1 billion, removing near-term financing pressure.
Should investors sell immediately? Or is it worth buying IonQ?
That liquidity cushion is crucial because IonQ is particularly vulnerable to rising interest rates. As an unprofitable growth stock, any upward move in risk-free rates tends to compress valuations. The selloff last week had no company-specific trigger — it was purely macro, with fears of sticky inflation and a potential slowdown in AI spending hitting high-duration equities hardest.
Technically, the stock sits in a volatile zone. The relative strength index reads 56, neutral territory, but the share price is roughly 36% above its 50-day moving average of €40.11. The annualised 30-day volatility is a staggering 165%. From its March low of €22.60, IonQ has rallied 142.83%, yet it remains 22.70% below its recent high of €71.00. The 30-day volatility remains extreme.
Institutional investors are sending mixed signals. CIBC World Market trimmed its position by 13.5%, while Ameriflex Group boosted its holdings by 485.7% and Accent Capital Management by 171.8%. The divergent moves reflect the fundamental debate: strong revenue growth and a clear strategic bet on vertical integration versus persistent losses and macro sensitivity.
The next major catalyst is the closing of the SkyWater deal. Until then, IonQ’s stock will likely swing with interest rate expectations and any new government orders that give tangible backing to the raised guidance. The quantum sector’s dream is intact, but the cold math of cash burn and rising rates demands proof of execution.
Ad
IonQ Stock: Buy or Sell?! New IonQ Analysis from June 9 delivers the answer:
The latest IonQ figures speak for themselves: Urgent action needed for IonQ investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 9.
IonQ: Buy or sell? Read more here...
